Related Experiment Videos
Summary
Metronidazole, a common treatment for trichomoniasis, can cause drug-induced eruptions. This case highlights a patient experiencing recurrent skin lesions linked to long-term intermittent metronidazole use.
Area of Science:
- Dermatology
- Pharmacology
- Infectious Diseases
Background:
- Trichomoniasis is a common sexually transmitted infection.
- Metronidazole is a widely prescribed antibiotic and antiprotozoal agent.
- Adverse drug reactions can manifest as various dermatological conditions.
Observation:
- A 37-year-old woman presented with chronic, dark brown plaques on her hip and knee.
- These lesions periodically became inflamed, erythematous, and painful.
- The patient reported a 20-year history of intermittent metronidazole use for trichomoniasis.
Findings:
- A drug challenge confirmed metronidazole as the causative agent for the patient's recurrent skin eruptions.
- The clinical presentation was consistent with a delayed hypersensitivity reaction to metronidazole.
- Discontinuation of metronidazole is indicated for managing such adverse reactions.
Implications:
- This case underscores the importance of considering medication side effects in chronic dermatological conditions.
- Healthcare providers should inquire about long-term medication use, especially intermittent therapies.
- Awareness of potential metronidazole-induced dermatoses can prevent misdiagnosis and unnecessary treatments.